Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
Ina Research Incorporation
sales of 2.12 billion Japanese Yen [US$18.46 million]
of which 80%
was Non-clinical business),
Pharma Foods International Co.Ltd
(3.46 billion Japanese Yen [US$30.18 million]
of which 60%
was Functional product(Online business)), and
Hester Pharmaceuticals Limited
based in India
(1.01 billion Indian Rupees [US$14.79 million]
of which 91%
was Poultry Vaccines).
Atect Corp reported sales of ¥2.47 billion (US$21.57 million)
March of 2016.
increase of 4.7%
versus 2015, when the company's sales were ¥2.36 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Atect Corp
reported sales of ¥2.50 billion.
Sales of Pim saw an increase
that was more than double the company's growth rate: sales were up
27.9% in 2016, from
¥83.02 million to ¥106.15 million.
Atect Corp also saw significant increases in sales in
Semiconductor Material (up 7.7% to ¥793.50 million)